KT-253
kymera therapeutics
['$kymr', 'kymera ']
$kymr kymera therapeutics, inc. will present preclinical data on kt-253, a potent and selective heterobifunctional mdm2 degrader. the data will be presented at the european hematology association (eha) congress, taking place from june 8-15, 2023, in ... 
Financial news recaps and ticker rating curated by AI language models. Fine tuned on analyst articles and return alpha. More exposure to lesser known companies.